XML 52 R35.htm IDEA: XBRL DOCUMENT v3.25.2
Earnings Per Share (Tables)
6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings Per Share
Shares used in the computation of the Company’s basic and diluted earnings per share are as follows:
(in thousands, except per share data)Three Months Ended June 30,Six Months Ended June 30,
 2025202420252024
Numerator
Net increase (decrease) in net assets resulting from operations$78,887 $41,852 $129,224 $132,816 
Less: Total distributions declared(83,083)(77,894)(164,467)(153,925)
Total Earnings (loss), net of total distributions(4,196)(36,042)(35,243)(21,109)
Earnings (loss), net of distributions attributable to common shares(4,196)(36,042)(35,244)(21,110)
Add: Distributions declared attributable to common shares82,381 77,157 162,997 152,387 
Numerator for basic change in net assets per common share78,185 41,115 127,753 131,277 
Add: Income impact of assumed conversion of 2028 Convertible Notes4,0764,980 
Numerator for diluted change in net assets per common share$82,261 $41,115 $132,733 $131,277 
Denominator
Basic weighted average common shares outstanding176,809160,748173,231159,096
Incremental shares from assumed conversion of 2028 Convertible Notes13,3878,329
Common shares issuable581561599518
Weighted average common shares outstanding assuming dilution190,777161,309182,159159,614
Change in net assets per common share:
Basic$0.44 $0.26 $0.74 $0.83 
Diluted$0.43 $0.25 $0.73 $0.82 
Schedule of Number of Anti-diluted Shares as Calculated Based on Weighted Average Closing Price of Common Stock
The calculation of change in net assets resulting from operations per common share assuming dilution, excludes all anti-dilutive shares. For the three and six months ended June 30, 2025 and 2024, the number of anti-dilutive shares, as calculated based on the weighted average closing price of the Company’s common stock for the periods, are as follows:
Three Months Ended June 30,Six Months Ended June 30,
Anti-dilutive Securities2025202420252024
Unvested common stock options1487981,0611,401
Unvested restricted stock awards3,2601471,642521